103 related articles for article (PubMed ID: 9677832)
1. [Pharmacokinetic and pharmacodynamic aspects of angiotensin II antagonists. Focus on arterial hypertension].
da Silva PM
Rev Port Cardiol; 1998 Jun; 17(6):545-55. PubMed ID: 9677832
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.
Csajka C; Buclin T; Brunner HR; Biollaz J
Clin Pharmacokinet; 1997 Jan; 32(1):1-29. PubMed ID: 9012554
[TBL] [Abstract][Full Text] [Related]
4. [Angiotensin II AT1 receptor antagonists: clinical development and future perspectives].
Burnier M; Brunner HR
Therapie; 1998; 53(3):279-84. PubMed ID: 9773127
[TBL] [Abstract][Full Text] [Related]
5. The comparative pharmacology of angiotensin II receptor antagonists.
Burnier M; Maillard M
Blood Press Suppl; 2001; 1():6-11. PubMed ID: 11333013
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of arterial hypertension with angiotensin receptor blockers].
Nobre FL
Rev Port Cardiol; 1999 Apr; 18(4):407-12. PubMed ID: 10371849
[TBL] [Abstract][Full Text] [Related]
7. Management of hypertension: the advent of a new angiotensin II receptor antagonist.
Hedner T
J Hypertens Suppl; 1999 Jun; 17(2):S21-5. PubMed ID: 10465063
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonists role in arterial hypertension.
Hernández-Hernández R; Sosa-Canache B; Velasco M; Armas-Hernández MJ; Armas-Padilla MC; Cammarata R
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S93-9. PubMed ID: 11986904
[TBL] [Abstract][Full Text] [Related]
9. [Clinical pharmacology of angiotensin II receptor antagonists].
Hitzenberger G
Wien Med Wochenschr; 2001; 151(7-8):151-2. PubMed ID: 11450161
[TBL] [Abstract][Full Text] [Related]
10. Comparative antihypertensive effects of angiotensin II receptor antagonists.
Burnier M; Brunner HR
J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S278-82. PubMed ID: 10201883
[TBL] [Abstract][Full Text] [Related]
11. [Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology].
Hauser AC; Hörl WH
Wien Med Wochenschr; 2001; 151(7-8):160-4. PubMed ID: 11450164
[TBL] [Abstract][Full Text] [Related]
12. [Use of angiotensin-II-antagonists in hypertension].
Birkenhäger WH; de Leeuw PW
Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1397-402. PubMed ID: 10923148
[TBL] [Abstract][Full Text] [Related]
13. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
Johnston CI
Blood Press Suppl; 2000; 1():9-13. PubMed ID: 11059629
[TBL] [Abstract][Full Text] [Related]
15. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
17. The role of angiotensin II receptors and their antagonists in hypertension.
van Zwieten PA
Ann Ital Med Int; 2000; 15(1):85-91. PubMed ID: 10842896
[TBL] [Abstract][Full Text] [Related]
18. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
19. [Are the antagonists of angiotensin II AT1 receptors protectors of the kidney?].
Deray G
Arch Mal Coeur Vaiss; 1999 Jul; 92(7):903-7. PubMed ID: 10443311
[TBL] [Abstract][Full Text] [Related]
20. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
